F. Darstein

发表

Efficacy and safety of a conversion from the original tacrolimus and mycophenolate mofetil to the generics Tacpan® and Mowel® after liver transplantation

P. Galle, H. Lang, J. Vollmar, 2015, Drug design, development and therapy.

Efficacy and safety of direct-acting antiviral therapy in previous hard-to-treat patients with recurrent hepatitis C virus infection after liver transplantation: a real-world cohort

P. Galle, H. Lang, D. Grimm, 2017, Drug design, development and therapy.

Impact of pancreatic comorbidities in patients with end-stage liver disease on outcome after liver transplantation.

P. Galle, H. Lang, D. Grimm, 2014, European journal of internal medicine.

Cirrhosis risk score of the donor organ predicts early fibrosis progression after liver transplantation.

D. Schuppan, P. Galle, H. Lang, 2019, Journal of gastrointestinal and liver diseases : JGLD.

Urinary ethyl glucuronide (uEtG) as a marker for alcohol consumption in liver transplant candidates: a real-world cohort

P. Galle, K. Lackner, J. Marquardt, 2020, Zeitschrift für Gastroenterologie.

Preoperative left ventricular hypertrophy is associated with reduced patient survival after liver transplantation

G. Otto, D. Grimm, T. Zimmermann, 2013, Clinical transplantation.

Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update

M. Emdin, N. Sarswat, C. Rapezzi, 2022, Orphanet Journal of Rare Diseases.

Characteristics of Patients with Late- vs. Early-Onset Val30Met Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)

S. Gottlieb, C. Rapezzi, L. Amass, 2021, Neurology and Therapy.

Pretransplant coronary artery disease is a predictor for myocardial infarction and cardiac death after liver transplantation.

P. Galle, G. Otto, H. Lang, 2017, European journal of internal medicine.

New onset of diabetes after transplantation is associated with improved patient survival after liver transplantation due to confounding factor.

P. Galle, J. Schattenberg, H. Lang, 2015, European journal of internal medicine.

Hepatitis E virus genotype 3 is a common finding in liver‐transplanted patients undergoing liver biopsy for elevated liver enzymes with a low De Ritis ratio and suspected acute rejection: A real‐world cohort

P. Galle, J. Wenzel, H. Lang, 2018, Clinical transplantation.

Hepatitis E Is a Rare Finding in Liver Transplant Patients With Chronic Elevated Liver Enzymes and Biopsy-Proven Acute Rejection.

P. Galle, G. Otto, H. Lang, 2020, Transplantation proceedings.

Bevacizumab in combination with octreotide rescues a patient with liver cirrhosis, GAVE syndrome and refractory hemorrhage – a case report

J. Schattenberg, C. Labenz, R. Kloeckner, 2022, Zeitschrift für Gastroenterologie.

Organic Cation Transporter 1 (OCT1) mRNA expression in hepatocellular carcinoma as a biomarker for sorafenib treatment

P. Galle, J. Schattenberg, S. Koch, 2016, BMC Cancer.

Organic Cation Transporter 1 (OCT1) mRNA expression in hepatocellular carcinoma as a biomarker for sorafenib treatment

P. Galle, J. Schattenberg, S. Koch, 2016, BMC Cancer.

Successful treatment of Erdheim–Chester disease with combination of interleukin‐1‐targeting drugs and high‐dose glucocorticoids

A. Schwarting, M. Schuchmann, T. Zimmermann, 2014, Internal medicine journal.

Recipient liver function before liver transplantation influences post-transplantation survival in patients with HCC.

P. Galle, G. Otto, J. Schattenberg, 2018, European journal of internal medicine.

Preoperative left ventricular hypertrophy is associated with reduced patient survival after liver transplantation

G. Otto, D. Grimm, J. Mittler, 2014, Clinical transplantation.